Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study
2019 ◽
Vol Volume 11
◽
pp. 1363-1372
◽
2020 ◽
Vol 9
(3)
◽
pp. 603-616
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 10580-10580
◽
Keyword(s):
2011 ◽
Vol 41
(4)
◽
pp. 548-554
◽
Keyword(s):
2013 ◽